Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nu Image Medical vs telos rx

Nu Image Medical
Site position #185

Lower grade

vs+18.1
telos rx
Site position #14

Higher grade

The verdict

telos rx takes it — 85.4/100 to 67.3/100.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified, HIPAA telehealth with one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide (oral and microdosed routes included) alongside PT-141, intranasal NAD+, and a long recovery/GH peptide bench — with compounded GLP-1 starting from $49/mo on an annual plan.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuetelos rx +14
73
87
Dose & formulationtelos rx +15
75
90
Clinical oversighttelos rx +14
70
84
Labs & monitoringtelos rx +28
52
80
Fulfillmenttelos rx +22
65
87
Contract termstelos rx +25
55
80
Nu Image Medical · left bartelos rx · right bar

The numbers

MetricNu Image Medicaltelos rx
WeighScore67.3/10085.4/100
GradeCB
Site position#185#14
SemaglutideFrom $99/mo injection on 12-month supply; RDT from $269/mo$99/mo injectable — the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks
TirzepatideFrom $289/mo injection; RDT from $314/mo$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)
CoverageCoverage not publishedNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Nu Image Medical

Site position #185 · C

Strengths

  • Separate public product pages identify both medications and oral formats
  • Publishes injection and tablet starting rates

Where it loses points

  • Lowest semaglutide injection rate requires a twelve-month supply
  • Final charge, renewal and dose-specific terms need confirmation
  • Compounded tablets are not FDA-approved brand-name pills
telos rx

Site position #14 · B

Strengths

  • Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
  • Needle-free and oral GLP-1 options, not injection-only
  • LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
  • Low GLP-1 entry — from $49/mo microdosed on an annual plan

Where it loses points

  • Everything is compounded and not FDA-approved, including the peptides
  • Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
  • No named clinicians and thin third-party reviews
  • Several research-grade peptides carry limited clinical evidence

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard